Preprint · OA
via OpenAlex
The Role of Vascular Endothelial Growth Factor in Neurodegeneration and Cognitive Decline: Exploring Interactions With Biomarkers of Alzheimer Disease
Timothy J. Hohman, Susan P. Bell, Angela Lee Jefferson
JAMA Neurology · 2015 · ▲ 201 citations
Abstract
IMPORTANCE: A subset of older adults present post mortem with Alzheimer disease (AD) pathologic features but without any significant clinical manifestation of dementia. Vascular endothelial growth factor (VEGF) has been implicated in staving off AD-related neurodegeneration. OBJECTIVE: To evaluate whether VEGF levels are associated with brain aging outcomes (hippocampal volume and cognition) and to further evaluate whether VEGF modifies relations between AD biomarkers and brain aging outcomes. DESIGN, SETTING, AND PARTICIPANTS: Biomarker analysis using neuroimaging and neuropsychological outcomes from the Alzheimer's Disease Neuroimaging Initiative. This prospective longitudinal study across North America included individuals with normal cognition (n = 90), mild cognitive impairment (n = 130), and AD (n = 59) and began in October 2004, with follow-up ongoing. MAIN OUTCOMES AND MEASURES: Cerebrospinal fluid VEGF was cross-sectionally related to brain aging outcomes (hippocampal volume, episodic memory, and executive function) using a general linear model and longitudinally using mixed-effects regression. Alzheimer disease biomarker (cerebrospinal fluid β-amyloid 42 and total tau)-by-VEGF interactions evaluated the effect of VEGF on brain aging outcomes in the presence of enhanced AD biomarkers. RESULTS: Vascular endothelial growth factor was associated with baseline hippocampal volume (t277 = 2.62; P = .009), longitudinal hippocampal atrophy (t858 = 2.48; P = .01), and longitudinal decline in memory (t1629 = 4.09; P < .001) and executive function (t1616 = 3.00; P = .003). Vascular endothelial growth factor interacted with tau in predicting longitudinal hippocampal atrophy (t845 = 4.17; P < .001), memory decline (t1610 = 2.49; P = .01), and executive function decline (t1597 = 3.71; P < .001). Vascular endothelial growth factor interacted with β-amyloid 42 in predicting longitudinal memory decline (t1618 = -2.53; P = .01). CONCLUSIONS AND RELEVANCE: Elevated cerebrospinal fluid VEGF was associated with more optimal brain aging in vivo. The neuroprotective effect appeared strongest in the presence of enhanced AD biomarkers, suggesting that VEGF may be particularly beneficial in individuals showing early hallmarks of the AD cascade. Future work should evaluate the interaction between VEGF expression in vitro and pathologic burden to address potential mechanisms.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1001/jamaneurol.2014.4761
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Hohman, T.J., Bell, S.P., & Jefferson, A.L. (2015). The Role of Vascular Endothelial Growth Factor in Neurodegeneration and Cognitive Decline: Exploring Interactions With Biomarkers of Alzheimer Disease. <em>JAMA Neurology</em>. https://doi.org/10.1001/jamaneurol.2014.4761
Vancouver
Hohman TJ, Bell SP, Jefferson AL. The Role of Vascular Endothelial Growth Factor in Neurodegeneration and Cognitive Decline: Exploring Interactions With Biomarkers of Alzheimer Disease. JAMA Neurology. 2015. doi:10.1001/jamaneurol.2014.4761.
BibTeX
@unpublished{timothy2015TheRol,
title = {The Role of Vascular Endothelial Growth Factor in Neurodegeneration and Cognitive Decline: Exploring Interactions With Biomarkers of Alzheimer Disease},
author = {Timothy J. Hohman and Susan P. Bell and Angela Lee Jefferson},
journal = {JAMA Neurology},
year = {2015},
doi = {10.1001/jamaneurol.2014.4761},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015
Open access · OA
Inhibition of PMCA activity by tau as a function of aging and Alzheimer's neuropathology
Frontiers in aging neuroscience 2026
Citation only
Atherosclerotic cardiovascular disease risk is associated with AT(N)V neuroimaging biomarkers and cognitive impairment in the health and aging brain study-health disparities cohort.
US Department of Veterans Affairs 1998
Open access · US-GOV
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Innovation in Aging 2024
Open access · CC-BY
EFFECT OF TIME-RESTRICTED EATING ON NEUROVASCULAR COUPLING AND METABOLIC PROFILE IN OLDER ADULTS
Eunoe 2001
Open access · US-GOV
Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System
Journal of Hypertension 2007
Citation only